Kelsey Stephen Michael 4
4 · Revolution Medicines, Inc. · Filed Oct 16, 2024
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-10-14$4.09/sh+16,666$68,164→ 281,074 total - Sale
Common Stock
2024-10-14$50.08/sh−2,610$130,702→ 264,408 total - Sale
Common Stock
2024-10-14$49.38/sh−14,056$694,102→ 267,018 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-14−16,666→ 23,332 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (16,666 underlying)
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.
- [F2]Includes 86,400 restricted stock units.
- [F3]The transaction was executed in multiple trades in prices ranging from $48.95 to $49.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The transaction was executed in multiple trades in prices ranging from $49.95 to $50.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.